Cafepharma Today

May 28 2025 - GLP-1 prescriptions for weight loss soar, despite obstacles
GLP-1 prescriptions for weight loss soar, despite obstacles
FDA approves use of Sanofi's meningococcal vaccine in infants
GSK's $66M bet on Spero's rejected UTI antibiotic pays off with a phase 3 win
AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FTC: ‘Tide May Be Turning’ On Pay-To-Delay Deals
Pharmalot
Thursday, July 29, 2010 - 10:55am
tags:
FTC, pay-for-delay, Apotex, Watson Pharmaceuticals, Solvay, Abbott Laboratories, generics
Sanofi Board Said to Support Genzyme Bid of Up to $18.7 Billion
Bloomberg
Thursday, July 29, 2010 - 10:50am
tags:
Genzyme, M&A, Sanofi
Even After Patent Cliff, Pfizer Is Undervalued
Yahoo/Morningstar
Thursday, July 29, 2010 - 10:48am
tags:
Pfizer, patents
Bayer Cuts Full-Year Forecasts at Two of Three Units as Profit Declines
Bloomberg
Thursday, July 29, 2010 - 10:40am
tags:
Bayer, earnings
Sanofi Second-Quarter Profit Climbs 7.6% on Demand for Diabetes Medicines
Bloomberg
Thursday, July 29, 2010 - 10:38am
tags:
earnings, Sanofi
Alexza Pharmaceuticals: Warming Up or Cooling Off?
Motley Fool
Thursday, July 29, 2010 - 10:36am
tags:
Alexza
What Investors Think About Allos Therapeutics
Motley Fool
Thursday, July 29, 2010 - 10:35am
tags:
Allos, investors
[video] Sanofi-aventis video Q&A: CEO Chris Viehbacher comments on earnings for Q2 2010
Yahoo
Thursday, July 29, 2010 - 10:33am
tags:
Sanofi, Chris Viehbacher, earnings, Pharma CEOs
AstraZeneca second-quarter net profit rises 23%
Marketwatch
Thursday, July 29, 2010 - 10:28am
tags:
earnings, AstraZeneca
A Novartis Giveaway of Medicine
NY Times, NY
Thursday, July 29, 2010 - 10:26am
tags:
Novartis
Top 5 Biotech VC Deals of 2010
Fierce Biotech
Wednesday, July 28, 2010 - 11:35pm
tags:
venture capital, biotech, Tesaro, Archimedes Pharma, Achaogen, NGM Biopharmaceuticals, Neurotherapeutics Pharma
Sanofi set to make offer for Genzyme
FT.com
Wednesday, July 28, 2010 - 11:26pm
tags:
Sanofi, Genzyme, M&A
Allos Therapeutics' Folotyn meets study goal
Yahoo/AP
Wednesday, July 28, 2010 - 11:24pm
tags:
Allos, Folotyn, lung cancer
Mylan 2Q net income falls 11 percent on charges
Yahoo/AP
Wednesday, July 28, 2010 - 11:21pm
tags:
Mylan, earnings
Dendreon Gets Some Respect
Forbes
Wednesday, July 28, 2010 - 11:20pm
tags:
Dendreon, Provenge, New England Journal of Medicine, prostate cancer
Federal judge upholds a ruling invalidating a use patent for blockbuster Eli Lilly drug Gemzar
Yahoo/AP
Wednesday, July 28, 2010 - 11:18pm
tags:
Eli Lilly, Gemzar, patents, cancer, generics
Earnings Preview: Merck to report 2Q results
Yahoo/AP
Wednesday, July 28, 2010 - 11:16pm
tags:
Merck, earnings
Novo's Victoza drains new scrips from rivals
Fierce Pharma
Wednesday, July 28, 2010 - 11:15pm
tags:
Novo Nordisk, Victoza, diabetes, Byetta, Eli Lilly
U.S. experts back AstraZeneca blood thinner
Reuters
Wednesday, July 28, 2010 - 11:13pm
tags:
FDA, blood thinners, AstraZeneca, Brilinta, advisory panels
Fighting Hard to Keep a Blockbuster
Motley Fool
Wednesday, July 28, 2010 - 11:11pm
tags:
Sanofi, generics, Lovenox, Teva Pharmaceuticals, Pfizer, Momenta, Novartis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.